Add
TNUS.OB to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| TNUS.OB > SEC Filings for TNUS.OB > Form 8-K on 3-Nov-2009 | All Recent SEC Filings |
3-Nov-2009
Regulation FD Disclosure, Financial Statements and Exhibits
On November 1, 2009, Total Nutraceutical Solutions issued a press release
announcing that it has entered into an agreement with Model BioSystems, Inc.
(MBS) to test proprietary mushroom compounds in suppressing Alzheimer's disease.
TNS was informed by MBS that a recent experiment in Drosophila melanogaster
fruit flies showed that certain TNS proprietary mushrooms had unusual
anti-inflammatory activity. MBS was of the opinion that TNS should evaluate
these mushroom samples in a special MBS biologic model for Alzheimer's disease.
A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference in its entirety.
(c) Exhibits
99.1 Press release issued on November 1, 2009 by the Company.*
* This exhibit is intended to be furnished and shall not be deemed "filed" for purposes of the Securities Exchange Act of 1934, as amended.
|
|